Search
Search Constraints
You searched for: Author/Creator Clippinger, Amy J.Limit your search
- Clippinger, Amy J. [remove] 9
- Toxicology -- Periodicals 6
- 615.9 5
- Toxicity testing -- In vitro -- Periodicals 3
- 658.403 2
- Technology -- Risk assessment -- Periodicals 2
- 363.179 1
- 615.37 1
- ADME absorption distribution metabolism and elimination -- AEP aggregate exposure pathway -- AOP adverse outcome pathway -- BAL bronchoalveolar lavage -- BEAS-2B adenovirus-12 SV40 hybrid transformed, non-tumorigenic human bronchial epithelial cells -- CFD model computational fluid dynamics model -- CxT concentration x time exposure -- dae aerodynamic diameter -- DAF dosimetric adjustment factor -- HBE cells human bronchial epithelial cells -- HEC human equivalent concentration -- IATA integrated approach to testing and assessment -- IVIVE in vitro to in vivo extrapolation -- KE key event -- LC50 lethal concentration 50% -- MMAD mass median aerodynamic diameter -- MIE molecular initiating event -- MPPD model Multiple-Path Particle Dosimetry model -- NICEATM NTP Interagency Center for the Evaluation of Alternative Toxicological Methods -- NSAIDs nonsteroidal anti-inflammatory drugs -- NTP National Toxicology Program -- OECD Organisation for Economic Co-operation and Development -- PBPK model physiologically based pharmacokinetic model -- POE portal of entry -- PCLS precision-cut lung slices -- QSAR quantitative structure-activity relationship -- RDDR regional deposited dose ratio -- REACH Registration, Evaluation, Authorisation and Restriction of Chemicals -- RGDR regional gas dose ratio -- RRDR regional retained dose ratio -- SAEC small airway epithelial cells -- TG test guideline -- TSE target site exposure 1
- Acute inhalation toxicity -- Alternative approaches -- Dosimetry -- In vitro -- In silico -- Globally harmonized system (GHS) additivity formula 1
- Acute inhalation toxicity -- In vitro -- In silico -- Ex vivo -- Quantitative structure-activity relationships (QSAR) -- Adverse outcome pathway -- Aggregate exposure pathway -- Dosimetry -- Integrated approach to testing and assessment (IATA) -- Risk assessment 1